Vancouver Sun
<img alt="" height="1" width="1" />
Gilead's Viread Reduces HIV Risk for Drug Users in Study
Bloomberg
Gilead Sciences Inc.'s Viread pill reduced the risk of injected-drug users contracting the AIDS virus by half in a study in Thailand, a finding that may give public health officials a new weapon to fight HIV's spread. In a trial involving 2,413 HIV-negative drug ...
HIV drug can also protect injection drug usersPioneer Press
all 15 news articles »
More...